These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia. Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046 [TBL] [Abstract][Full Text] [Related]
46. Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study. Buckley RF; O'Donnell A; McGrath ER; Jacobs HIL; Lois C; Satizabal CL; Ghosh S; Rubinstein ZB; Murabito JM; Sperling RA; Johnson KA; Seshadri S; Beiser AS Ann Neurol; 2022 Jul; 92(1):11-22. PubMed ID: 35471588 [TBL] [Abstract][Full Text] [Related]
47. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077 [TBL] [Abstract][Full Text] [Related]
48. Divergent Network Patterns of Amyloid-β Deposition in Logopenic and Amnestic Alzheimer's Disease Presentations. Leyton CE; Cassidy B; Villemagne VL; Jones G; Kwok JB; Rowe CC; Ballard KJ; Piguet O; Hodges JR Biol Psychiatry Cogn Neurosci Neuroimaging; 2016 Jan; 1(1):24-31. PubMed ID: 29560892 [TBL] [Abstract][Full Text] [Related]
49. Sex influences the effects of APOE genotype and Alzheimer's diagnosis on neuropathology and memory. Duarte-Guterman P; Albert AY; Barha CK; Galea LAM; On Behalf Of The Alzheimer's Disease Neuroimaging Initiative Psychoneuroendocrinology; 2021 Jul; 129():105248. PubMed ID: 33962245 [TBL] [Abstract][Full Text] [Related]
50. The link between C-reactive protein and Alzheimer's disease among Mexican Americans. O'Bryant SE; Johnson L; Edwards M; Soares H; Devous MD; Ross S; Rohlfing G; Hall J; J Alzheimers Dis; 2013; 34(3):701-6. PubMed ID: 23254637 [TBL] [Abstract][Full Text] [Related]
51. Association between APOE genotype, neuropathology and dementia in the older population of England and Wales. Nicoll JA; Savva GM; Stewart J; Matthews FE; Brayne C; Ince P; Neuropathol Appl Neurobiol; 2011 Apr; 37(3):285-94. PubMed ID: 20880354 [TBL] [Abstract][Full Text] [Related]
52. Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease. Leuzy A; Binette AP; Vogel JW; Klein G; Borroni E; Tonietto M; Strandberg O; Mattsson-Carlgren N; Palmqvist S; Pontecorvo MJ; Iaccarino L; Stomrud E; Ossenkoppele R; Smith R; Hansson O; JAMA Neurol; 2023 Jun; 80(6):614-623. PubMed ID: 37155176 [TBL] [Abstract][Full Text] [Related]
53. Using Fractional Anisotropy Imaging to Detect Mild Cognitive Impairment and Alzheimer's Disease among Mexican Americans and Non-Hispanic Whites: A HABLE Study. Hall JR; Johnson LA; Zhang F; Petersen M; Toga AW; Shi Y; Mason D; Rissman RA; Yaffe K; O'Bryant SE; Dement Geriatr Cogn Disord; 2021; 50(3):266-273. PubMed ID: 34569492 [TBL] [Abstract][Full Text] [Related]
54. Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population. Rimajova M; Lenzo NP; Wu JS; Bates KA; Campbell A; Dhaliwal SS; McCarthy M; Rodrigues M; Paton A; Rowe C; Foster JK; Martins RN J Alzheimers Dis; 2008 Mar; 13(2):137-46. PubMed ID: 18376055 [TBL] [Abstract][Full Text] [Related]
55. Patterns of Focal Amyloid Deposition Using Chung SE; Kim HJ; Jo S; Lee S; Lee Y; Roh JH; Lee JH Diagnostics (Basel); 2022 May; 12(6):. PubMed ID: 35741166 [TBL] [Abstract][Full Text] [Related]
56. Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults. Donovan NJ; Okereke OI; Vannini P; Amariglio RE; Rentz DM; Marshall GA; Johnson KA; Sperling RA JAMA Psychiatry; 2016 Dec; 73(12):1230-1237. PubMed ID: 27806159 [TBL] [Abstract][Full Text] [Related]
57. Association of cardiovascular risk factors and blood biomarkers with cognition: The HABS-HD study. Jiang X; O'Bryant SE; Johnson LA; Rissman RA; Yaffe K; Alzheimers Dement (Amst); 2023; 15(1):e12394. PubMed ID: 36911361 [TBL] [Abstract][Full Text] [Related]
58. Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease. Yin Y; Liu Y; Pan X; Chen R; Li P; Wu HJ; Zhao ZQ; Li YP; Huang LQ; Zhuang JH; Zhao ZX PLoS One; 2016; 11(3):e0149945. PubMed ID: 26937653 [TBL] [Abstract][Full Text] [Related]
59. Differential Aging Trajectories of Modulation of Activation to Cognitive Challenge in APOE ε4 Groups: Reduced Modulation Predicts Poorer Cognitive Performance. Foster CM; Kennedy KM; Rodrigue KM J Neurosci; 2017 Jul; 37(29):6894-6901. PubMed ID: 28652414 [TBL] [Abstract][Full Text] [Related]
60. Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity. Duara R; Loewenstein DA; Lizarraga G; Adjouadi M; Barker WW; Greig-Custo MT; Rosselli M; Penate A; Shea YF; Behar R; Ollarves A; Robayo C; Hanson K; Marsiske M; Burke S; Ertekin-Taner N; Vaillancourt D; De Santi S; Golde T; St D Neuroimage Clin; 2019; 22():101800. PubMed ID: 30991618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]